Explore our Resources
Access a curated collection of materials designed to provide insights into our capabilities and expertise across the drug development and manufacturing lifecycle.

Access a curated collection of materials designed to provide insights into our capabilities and expertise across the drug development and manufacturing lifecycle.
What this whitepaper covers: Why lyophilization has become a defining constraint in modern biologics development — and how a QbD-led, integrated approach transforms cycle design into a scalable, regulatory-ready system. Whitepaper Abstract:…
The quiet revolution in how we take our medicine Ravi Kumar, Global Head of Injectables & Corporate Strategy, Portfolio and SPO Published on Money Control, 05 Jun 2026 Three out of four…
Solubility is broken. The pipeline proves it. What this whitepaper covers: Why solubility failure is the defining challenge of modern oral drug development — and how self-emulsifying softgel technology (SEDDS/SMEDDS/SNEDDS) unlocks bioavailability…
The subcutaneous shift has already happened. Is your pipeline ready? In 2000–2004, 25% of FDA biologic approvals were device-based. By 2023-2025, 74% were. OneSource delivers the complete subcutaneous (SC) development stack –…
GLP-1 peptide therapeutics are rapidly reshaping the treatment landscape for diabetes and obesity, increasing the need for robust formulation development and comprehensive analytical characterization strategies that enable safe, scalable, and market-ready drug…
Supply chain resilience is not an insurance cost, but value protection Anurag Bhagania, Chief Financial Officer Published on BW CFO World, 14 Apr2026 For a long time, the ‘ideal’ supply chain was…
CDMOs as innovation partners in R&D Prateek Gupta, SVP & head, Technical Development Published on Hindustan Times, 22 Mar 2026 Pharma research and development (R&D) is moving faster and getting harder at…